Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Branchlab, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 SaaS story that mention DeepIntent, all published on July 2, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about DeepIntent
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Branchlab, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 SaaS story that mention DeepIntent, all published on July 2, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering DeepIntent. Shared-story counts are live from our verified record — not editorial picks.
The pharma industry's pivot to digital is fueling a new class of vertical SaaS platforms that unseat horizontal ad tech. Companies like DeepIntent and Pulsepoint are capitalizing on regulatory complexity to carve out a defensible niche.
DeepIntent is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.